Summertime Actinic Lichenoid Eruption (SALE)

Summertime actinic lichenoid eruption (SALE) is a sun-induced, seasonal skin disorder. It is part of the lichenoid family of rashes, which means the top layer of the skin reacts with an “interface” inflammation where the epidermis meets the dermis. In SALE, ultraviolet (UV) light—usually in late spring or summer—triggers itchy, flat-topped bumps or plaques on sun-exposed areas such as the face, neck, forearms, and the back of the hands. The color can look pink-violet at first and then turn brown as it heals. The eruption often spares covered skin under clothing and under watch straps or jewelry, which helps doctors recognize it. Children, teens, and young adults in sunny climates can be affected, but adults can get it too. Darker skin phototypes (for example Fitzpatrick IV–VI) may show more obvious pigmentation after inflammation. The rash can recur every warm season, improve in cooler months, and leave behind dark marks. On biopsy, doctors see a classic lichenoid pattern: a dense, band-like lymphocytic infiltrate at the dermo-epidermal junction, basal cell damage (Civatte bodies), and a compact, scaly top layer. SALE is not contagious and is not skin cancer, but it can look alarming and feel very itchy. The good news: careful sun protection, short courses of anti-inflammatory treatment, and elimination of light-sensitizing triggers usually control it well.

Summertime actinic lichenoid eruption, or SALE, is a sun-triggered skin problem. It causes small, itchy, flat-topped bumps (papules) that cluster on sun-exposed skin such as the face, neck, arms, and the backs of the hands. It often starts or flares in the hot months when sunlight is stronger and people spend more time outdoors. Doctors consider SALE to be part of the lichenoid family of rashes (rashes that look like lichen planus under the microscope). Many experts think SALE is closely related to actinic (sun-induced) lichen nitidus or a photodistributed form of lichen planus called lichen planus actinicus. Sunlight is the main trigger, and phototesting in classic reports confirmed that UV exposure can bring the rash out. The condition usually improves with sun protection and topical corticosteroid creams, but tends to recur in later summers. PubMedThe Hospitalist BlogKargerIJDVL

---

Another names

SALE belongs to the spectrum of actinic lichen planus and is often discussed under these synonyms: Lichen planus actinicus (LPA), actinic lichen planus, El-Mofty syndrome, lichen planus subtropicus, and summertime actinic lichenoid eruption (SALE). In some reports, it overlaps with entities described as actinic lichenoid dermatosis or photodistributed lichenoid eruption. These names all point to the same idea: a lichenoid rash triggered or worsened by actinic (light) exposure—most often UVA and UVB sunlight—and showing a similar interface dermatitis under the microscope. The terms differ mainly by region, patient population, and how the rash looks (papules, plaques, or hyperpigmented patches).

---

Types

1) Classic papulo-plaque type
This is the most common look. Small, flat-topped itchy papules merge into plaques on the forehead, temples, cheeks, “V” of the neck, dorsal forearms, and hands. The borders are often sharp because the light exposure is sharp. Lesions may be pink-violaceous at first and then resolve with brown post-inflammatory pigmentation.

2) Annular (ring-shaped) type
Some plaques spread outward with central clearing, forming rings. The annular shape reflects activity at the rim and healing in the center. It often appears on the forearms and sides of the face and can be mistaken for fungal infections, but it does not respond to antifungal creams.

3) Dyschromic/hyperpigmented patch type
In darker skin tones, the eruption may present mainly as slate-gray to brown patches without obvious bumps. The patches are photodistributed and can look like melasma at a glance, but they itch more and show a lichenoid pattern on biopsy.

4) Actinic cheilitis-like lip variant
The lower lip, which receives more sun, can show burning, dryness, scale, and a lichenoid rim. This must be differentiated from true actinic cheilitis (a precancerous condition) by exam and, when needed, biopsy.

5) Pediatric/teenage seasonal variant
In some regions, children and teenagers get SALE every hot season. It starts in late spring, peaks in summer holidays when outdoor time rises, and fades in autumn with careful protection and short, safe treatment courses.

6) Spectrum by light sensitivity (UVA-dominant, UVB-dominant, visible-light–augmented)
Some patients flare more with UVA, some with UVB, and some react to visible light as well (for example, blue light). Phototesting patterns help tailor protection (broad-spectrum sunscreen, clothing, and behavior).

7) Severity bands (mild, moderate, severe)
Mild cases show scattered papules with quick response to topicals. Moderate cases form plaques and require stricter light control and short systemic anti-inflammatories. Severe cases recur early each season, involve wide areas, and need proactive, preventive plans.

---

Causes

1) Ultraviolet A (UVA) exposure
UVA penetrates deeply and is abundant all day. It drives the interface inflammation that characterizes SALE. Window glass does not fully block UVA, so even indoor, sun-facing exposure can provoke flares.

2) Ultraviolet B (UVB) exposure
UVB is strongest at midday and causes classic sunburn. In SALE, UVB can directly injure basal keratinocytes, revealing antigens that T-cells then attack in a lichenoid pattern.

3) Visible light (especially blue light)
High-energy visible light can worsen pigment and sometimes sustain inflammation. Screens are weaker sources than sun, but strong daylight and reflective surfaces add visible light load.

4) Geographic latitude and high UV index
Living or vacationing in tropical/subtropical areas increases cumulative actinic dose in late spring and summer, which aligns with the seasonal timing of SALE.

5) Outdoor occupations and hobbies
Gardening, farming, construction, fishing, and sports increase unprotected exposure hours, raising the chance of seasonal flares.

6) Photosensitizing medications: thiazide diuretics
Hydrochlorothiazide and related drugs can make skin more photosensitive. In a person predisposed to lichenoid reactions, this can lower the threshold for SALE.

7) Photosensitizing antibiotics: tetracyclines
Doxycycline and other tetracyclines can amplify UV sensitivity, turning routine sunlight into a trigger for lichenoid eruptions.

8) Other photosensitizing drugs (NSAIDs, retinoids, some antifungals, phenothiazines)
Several drug classes raise UV sensitivity or directly cause lichenoid drug eruptions that look and behave like SALE in the sun.

9) Fragrances and plant phototoxins
Compounds like furocoumarins in limes, figs, and some perfumes can cause phototoxic injury and set off lichenoid inflammation in exposed areas.

10) Tar and certain dyes
Coal tar and para-phenylenediamine (hair dye) can cause contact/photo-allergy and prime the skin for a lichenoid response when sunlight hits.

11) Genetic susceptibility
Some HLA patterns and immune traits likely increase the chance of a lichenoid reaction when UV injury exposes new skin antigens.

12) Darker skin phototypes (IV–VI) and pigment pathways
Melanin pathways may modify how light is absorbed and how inflammation resolves, making pigmentation more prominent and sometimes more persistent.

13) Previous lichenoid conditions (lichen planus history)
A background tendency to lichenoid reactions can focus new inflammation in sun-exposed zones during summer.

14) Immune dysregulation or autoimmune background
Immune systems that respond strongly to minor triggers can convert small amounts of UV injury into sustained lichenoid interface dermatitis.

15) Viral co-factors (e.g., hepatitis C in the broader lichen planus spectrum)
In some populations, hepatitis C is linked with lichen planus. While not proven to cause SALE, co-occurrence may lower the threshold for flares.

16) Nutritional factors and barrier weakness
Low vitamin D, essential fatty acid imbalance, or general skin barrier fragility may not cause SALE alone but can worsen recovery after UV injury.

17) Heat and sweating
Heat increases blood flow and skin reactivity. Sweat plus sunlight can irritate and make the rash more noticeable and itchier.

18) Reflective environments
Water, sand, snow, or white paint reflect light and increase the effective dose, even under shade structures with side glare.

19) Inadequate sun protection routines
Irregular sunscreen use, missed reapplication, or narrow-spectrum products leave UVA gaps and permit seasonal flares.

20) Cumulative lifetime exposure and aging skin
Over time, repeated sun injury changes how the skin copes with light. Even without new drugs or illnesses, summer flares can appear in adults who never had them before.

---

Symptoms

1) Itchy, prickly rash on sun-exposed areas
Patients describe moderate to intense itch that worsens outdoors and calms in shade or air-conditioned rooms.

2) Flat-topped bumps (papules) that can merge into plaques
The lesions feel slightly rough or scaly on top. They may link together and form larger patches.

3) Seasonal timing
Onset in late spring, worst in mid-summer, and improvement in autumn is very typical. Recurrence can happen yearly.

4) Color change over time
Early lesions are pink to violaceous; later they turn brown or gray-brown as they resolve, especially in darker skin.

5) Sharp borders in exposed zones
You often see a clean edge at clothing lines, under watches, or under scarf edges. This “photocutoff” is a diagnostic clue.

6) Burning or stinging with sun
Beyond itch, some people feel a hot, burning sensation during midday exposure.

7) Dryness and fine scale
Many plaques have a dry, thin scale, especially on the forearms and cheeks.

8) Ring-shaped patches
Annular lesions with clearer centers can appear, especially on the arms.

9) Lip involvement
The lower lip can sting, become dry, and scale. Lip balm with sunscreen often helps.

10) Pigmentation that lingers
After the active rash settles, brown marks can last weeks to months.

11) Sleep disturbance from nocturnal itch
Itch tends to flare after sun exposure and can disrupt sleep that same night.

12) Cosmetic concern and anxiety
Facial and neck lesions can cause distress, reduced social confidence, and activity avoidance.

13) Tenderness on very inflamed plaques
Scratching and sunburn on top of lesions can make them sore to touch.

14) Koebner phenomenon (rash on scratch lines)
New papules may appear along minor scratches in exposed areas.

15) Lack of systemic symptoms
Fever, severe fatigue, or joint swelling are not typical of SALE; their presence suggests a different diagnosis.

---

Diagnostic tests

(Grouped as Physical Exam, Manual Tests, Lab/Pathological, Electrodiagnostic/Device-based, and Imaging. Each is explained simply.)

A) Physical Exam

1) Full-body, photodistribution inspection
The clinician looks for lesions only on sun-exposed areas with sharp clothing lines. Sparing of covered skin supports SALE. Involvement of face, neck “V,” forearms, and hands is classic.

2) Lesion morphology review
Flat-topped papules with a slightly scaly surface and violaceous or brown color suggest a lichenoid process. Annular rims and post-inflammatory pigment help the pattern recognition.

3) Mucosa, scalp, nail check
A quick check looks for oral lichen planus, scalp scale, or nail ridging. In SALE, mucosa and nails are usually normal, which helps rule in the actinic-limited variant.

4) Photocutoff assessment
Noting clear borders where clothing blocked the sun is an in-office, bedside “test” that points toward actinic triggers.

5) Symptom timeline and seasonality
A simple calendar history—late spring onset, peak in summer, autumn improvement—supports SALE over other rashes that do not follow seasons.

B) Manual Tests

6) Photoprotection trial (“shade test”)
A structured one-to-two-week trial of strict sun avoidance, broad-spectrum sunscreen, hats, and sleeves. Clear improvement strongly suggests a light-driven eruption.

7) Sunscreen challenge
Using a true broad-spectrum SPF 50+ with reapplication every 2 hours during similar outdoor exposure. Less flare under protection supports UV causation.

8) Standard patch testing (contact allergy screen)
If fragrance, dye, or topical products are suspected co-triggers, patch testing can find allergens that add to light-induced inflammation.

9) Photopatch testing (photo-contact allergy)
Patches with suspected products are applied and then irradiated on one side with UVA. A stronger reaction on the irradiated side shows photo-aggravated allergy mimicking SALE.

C) Lab and Pathological Tests

10) Skin biopsy—histopathology (gold standard for confirmation)
A small sample under local anesthesia is studied under the microscope. SALE shows lichenoid interface dermatitis: band-like lymphocytes at the junction, basal damage (Civatte bodies), wedge-shaped hypergranulosis, and a compact stratum corneum. This confirms the diagnosis and rules out look-alikes such as cutaneous lupus or drug eruptions.

11) Direct immunofluorescence (DIF) on biopsy (when needed)
DIF can help separate SALE/actinic LP (usually negative or nonspecific) from lupus (which shows granular immune deposits along the basement membrane).

12) Hepatitis C serology (selected patients)
Because classic lichen planus has an association with hepatitis C in some regions, testing may be considered if there are other risk factors or widespread lichenoid disease.

13) Antinuclear antibody (ANA) and lupus panel (if lupus is suspected)
If photosensitivity comes with systemic signs (mouth ulcers, joint pain, fatigue), lupus tests help rule out cutaneous lupus which can mimic SALE.

14) Complete blood count and liver enzymes (if drug reaction considered)
Drug-induced lichenoid eruptions can look like SALE. Basic labs can support medication safety checks during evaluation and treatment.

15) Porphyrin studies (if blistering or fragility suggests porphyria)
If there is blistering, milia, or skin fragility on the backs of the hands, testing for porphyria cutanea tarda helps exclude that photodermatosis.

D) Electrodiagnostic / Device-Based Assessments

16) MED/MPD phototesting (minimal erythema dose / minimal persistent pigment darkening)
Using calibrated UVB and UVA devices, clinicians find the lowest dose that causes redness or pigment darkening. Lower-than-expected thresholds and reproducible provocation support a light-sensitive condition.

17) Skin colorimetry (melanin/erythema index) for monitoring
A handheld, light-based meter objectively tracks redness and pigment changes over time. It does not diagnose SALE by itself but helps measure response to protection and therapy.

E) Imaging Tests

18) Dermoscopy (polarized light handheld imaging)
Dermoscopy can show surface scale, pigment network, and perifollicular features seen in lichenoid eruptions. The pattern supports the clinical impression and helps separate tinea or eczema.

19) Reflectance confocal microscopy (RCM) (when available)
RCM gives near-histologic, in-vivo views. Interface changes and inflammatory cells at the epidermal junction can be appreciated without a biopsy in select centers.

20) High-frequency ultrasound or optical coherence tomography (OCT) (advanced centers)
These show epidermal thickening and dermal inflammation as gray-scale or optical layers, useful for research and difficult cases where noninvasive monitoring is desired.

Non-pharmacological treatments

A) Physiotherapy / physical skin-care” measures

1. Daily broad-spectrum photoprotection (SPF 50+, UVA + UVB)

• Description (~150 words): Use a broad-spectrum SPF 50+ sunscreen every morning on all exposed skin, and reapply every 2 hours when outdoors. Choose water-resistant formulas for sweating or swimming. Apply at least a teaspoon for face/neck and a shot-glass (30 mL) for the whole body for full protection. Mineral options (zinc oxide, titanium dioxide) are good for sensitive skin; modern organic filters are fine if tolerated. Don’t forget ears, back of hands, part lines, and lips (SPF lip balm). Combine sunscreen with hats, shade, and clothing. Start 2–3 weeks before peak-sun seasons to reduce priming by early UV exposure.

• Purpose: Reduce the UV trigger that starts SALE.

• Mechanism: Blocks/absorbs UVA/UVB that cause the lichenoid reaction.

• Benefits: Fewer flares, milder lesions, faster healing; supports other treatments. (Actinic variants are UV-triggered.) PubMedDermNet®

2. UPF clothing, wide-brim hats, UV-blocking sunglasses

• Description: Wear UPF-rated long sleeves, densely woven fabrics, and a 7–10 cm brim hat. Add UV-blocking sunglasses to protect peri-ocular skin. Choose light, breathable fabrics for hot weather to keep adherence high.

• Purpose: Physical barrier against sunlight.

• Mechanism: UPF fabrics reduce UV transmission to skin.

• Benefits: Constant protection without reapplication; lowers flare risk. Karger

3. Shade and time-of-day planning

• Description: Plan outdoor activity before 10 a.m. or after 3–4 p.m., use shade structures, and track UV index on weather apps.

• Purpose: Reduce peak UV exposure.

• Mechanism: Limits cumulative UV dose.

• Benefits: Fewer lesions and less itch; complements sunscreen.

4. Window UV-film and car protection

• Description: Apply UVA-blocking films to home/car windows; keep car sunshades.

• Purpose: Cut indoor/passive UV exposure.

• Mechanism: Filters UVA, which penetrates glass.

• Benefits: Protects those with long commutes or sun-facing rooms.

5. Cool compresses during flares

• Description: Apply cool, damp cloths 5–10 minutes to calm burning/itch.

• Purpose: Symptom relief.

• Mechanism: Vasoconstriction and reduced nerve activation.

• Benefits: Less itch, less scratching → faster clearing.

6. Wet-wrap therapy for intense itch patches

• Description: After moisturizer (or prescribed topical), cover with damp cotton layer then a dry layer for 1–2 hours.

• Purpose: Enhance comfort and penetration of moisturizers or meds.

• Mechanism: Increases stratum corneum hydration; reduces transepidermal water loss.

• Benefits: Quick itch control; helps break scratch cycle.

7. Gentle, fragrance-free skin care and emollients

• Description: Use soap-free cleansers, short lukewarm showers, and thick moisturizers twice daily.

• Purpose: Repair the skin barrier.

• Mechanism: Restores lipids/water balance; reduces irritant penetration.

• Benefits: Less burning, better tolerance of topicals.

8. Oatmeal or bicarbonate soaks (itch soothers)

• Description: 10–15 minutes in colloidal oatmeal or a baking-soda bath can reduce itching without irritation.

• Purpose: Comfort care.

• Mechanism: Oat avenanthramides and pH modulation calm nerves.

• Benefits: Non-drug itch relief; improved sleep.

9. Nail care and anti-scratch strategies

• Description: Keep nails short and filed; use overnight cotton gloves during flares.

• Purpose: Prevent skin damage.

• Mechanism: Lowers mechanical trauma that amplifies lichenoid lesions (Koebner-like effect).

• Benefits: Fewer marks and faster healing.

10. Allergen/irritant minimization on exposed skin

• Description: Avoid fragrances, harsh exfoliants, retinoids, alcohol toners on sun-hit areas during season.

• Purpose: Reduce additive irritation.

• Mechanism: Less irritant contact dermatitis, which can worsen the rash.

• Benefits: Calmer skin, better treatment response.

11. Sweat and heat management

• Description: Wear breathable fabrics, use cooling towels/fans, take brief cool showers after outdoor heat.

• Purpose: Limit heat-induced itch and vasodilation.

• Mechanism: Reduces neurogenic itch pathways aggravated by heat.

• Benefits: Less urge to scratch; better comfort.

12. Targeted occlusion for small clusters (daytime)

• Description: For tiny, stubborn clusters, hydrocolloid dots or silicone sheets (daytime) can reduce friction and UV reach.

• Purpose: Protect hot-spots.

• Mechanism: Mechanical shield; micro-occlusion.

• Benefits: Less rubbing, faster flattening.

13. Protective make-up with iron oxides

• Description: Tinted sunscreens and mineral make-up with iron oxides add visible-light protection (helpful in darker skin tones).

• Purpose: Extra spectral coverage.

• Mechanism: Blocks high-energy visible light, which can contribute to pigment change.

• Benefits: More even tone; cosmetic acceptance.

14. Post-sun routine

• Description: After unavoidable sun, cleanse, moisturize, and re-cool skin; avoid actives that night.

• Purpose: Reduce delayed irritation.

• Mechanism: Restores barrier and calms neuroinflammation.

• Benefits: Fewer next-day flares.

15. Seasonal pre-emptive plan

• Description: Start strict photoprotection and gentle care 2–3 weeks before summer; have rescue measures ready.

• Purpose: Prevent priming.

• Mechanism: Lower cumulative UV dose before peak season.

• Benefits: Milder season, fewer doctor visits.

B) Mind-body, “gene,” and educational therapies

16. Itch-focused cognitive-behavioral therapy (CBT)

• Description (~150 words): Short CBT programs teach you to notice itch triggers (heat, stress, rumination), swap scratching for neutral responses (press, tap, cooling), and schedule response-prevention during peak-itch times (evening). Brief relaxation, paced breathing, and imagery reduce the emotional “fuel” for itch. Keeping a scratch diary links situations to symptoms so you can plan buffers (cooler clothing, breaks from sun). CBT can be delivered in a few sessions, via telehealth, or self-guided workbooks.

• Purpose: Reduce the itch–scratch–flare loop.

• Mechanism: Retrains central nervous system responses; lowers sympathetic arousal.

• Benefits: Less scratching, quicker lesion flattening, better sleep.

17. Relaxation and breathing (box breathing, progressive muscle relaxation)

• Purpose: Lower stress-driven itch.

• Mechanism: Down-regulates adrenergic itch pathways.

• Benefits: Calmer skin; complements medical care.

18. Mindfulness for urge surfing

• Purpose: Notice itch as a transient sensation; delay scratching.

• Mechanism: Improves interoceptive control.

• Benefits: Reduced excoriations and post-inflammatory marks.

19. Sleep hygiene program

• Purpose: Better sleep lowers itch perception and scratching at night.

• Mechanism: Stabilizes central pain/itch processing.

• Benefits: Fewer night flares; daytime energy improves.

20. Trigger education (sun, friction, photosensitizers)

• Description: Learn about sunlight, friction on elbows/forearms, and photosensitizing products/drugs (e.g., some antibiotics, thiazides, St John’s wort) so you can plan around them with your clinician.

• Purpose: Avoid preventable flares.

• Mechanism: Reduces exposure to provoking stimuli.

• Benefits: Better disease control. (Actinic variants are UV-triggered; frictional lichenoid eruptions in children can mimic.) PubMedPMC

21. Work/school sun-safety accommodations

• Purpose: Practical changes (shade breaks, clothing policies).

• Mechanism: Reduces workplace UV dose.

• Benefits: Sustained control without medication increases.

22. Skincare literacy coaching

• Purpose: Teach correct SPF amount, reapplication, and product layering.

• Mechanism: Improves real-world effectiveness of protection.

• Benefits: Fewer flares with the same products.

23. Digital UV-index and reminder tools

• Purpose: Real-time prompts to reapply SPF and seek shade.

• Mechanism: Behavioral nudging.

• Benefits: Better adherence; fewer surprise flares.

24. Family education

• Purpose: Aligns caregivers on sun safety for children or supports partners in reminding reapplication.

• Mechanism: Shared routines.

• Benefits: Consistent prevention.

25. “Gene therapy” note (important reality check)

• Description (~150 words): There is no approved gene therapy for SALE, actinic lichen nitidus, or lichen planus actinicus. These conditions are immune-mediated interface dermatoses, not single-gene disorders with known, safe, corrective gene targets. Research in inflammatory skin disease increasingly looks at immune signaling (e.g., JAK/STAT pathways) rather than gene replacement. Any websites promising gene therapy for this condition are not evidence-based. The best non-drug approach is UV avoidance and barrier support, while medical therapy focuses on topical anti-inflammatories and, for difficult cases, systemic immunomodulators under a dermatologist’s care.

• Purpose: Protect you from misinformation.

• Mechanism: Sets realistic expectations and safer choices.

• Benefits: Focus on proven, low-risk strategies. DermNet®

---

Drug treatments

Important: Medication choices must be individualized by a clinician. Many of the drugs below are off-label for SALE but are used for related lichenoid/actinic variants based on case experience.

1. Hydrocortisone 1% cream (low-potency topical corticosteroid)

• Description (~150 words): A mild steroid cream for itchy, inflamed clusters on the face or thin skin. Apply a thin layer once or twice daily for 1–2 weeks, then stop or taper to weekends to avoid overuse. Combine with sunscreen and clothing. Useful in children and sensitive areas because it has a lower risk of thinning than stronger steroids. If no improvement in a week, your doctor may step up potency or switch classes.

• Class: Topical corticosteroid (low potency).

• Dose/Time: Thin layer 1–2×/day for 1–2 weeks.

• Purpose: Calm local inflammation and itch.

• Mechanism: Glucocorticoid receptor reduces cytokines and T-cell skin attack.

• Side effects: Skin thinning with overuse, steroid acne, perioral dermatitis; rare allergy.

2. Triamcinolone 0.1% ointment (mid-potency topical steroid)

• Class: Topical corticosteroid (medium).

• Dose/Time: Thin layer 1–2×/day up to 2–3 weeks on body (avoid face).

• Purpose/Mechanism: Stronger anti-inflammatory effect for thicker plaques.

• Side effects: As above; avoid long use on face/flexures.

3. Clobetasol 0.05% (high-potency topical steroid)

• Class: Topical corticosteroid (super-potent).

• Dose/Time: Very short courses (e.g., 5–7 days) for stubborn small areas on non-facial skin only, then step down.

• Purpose/Mechanism: Rapid control of severe clusters.

• Side effects: High risk of atrophy/striae if misused—dermatology guidance needed.

4. Tacrolimus 0.1% ointment (topical calcineurin inhibitor)

• Description (~150 words): Steroid-sparing option for face/neck/hands. Apply 2×/day until clear, then maintenance 2–3×/week during sunny months. It does not thin skin and is safe for delicate sites. Mild burning can occur for a few days. Works best when combined with strict photoprotection.

• Class: Calcineurin inhibitor.

• Dose/Time: 2×/day, then maintenance.

• Purpose: Control inflammation where steroids are risky.

• Mechanism: Blocks T-cell activation (calcineurin pathway).

• Side effects: Transient stinging; very rare infection risk; sun care is essential.

5. Pimecrolimus 1% cream

• Class: Topical calcineurin inhibitor.

• Use/Dose: Similar to tacrolimus; often preferred for very sensitive, facial skin.

• Risks/benefits: Like tacrolimus; no skin thinning.

6. Oral antihistamines (cetirizine 10 mg nightly or fexofenadine 180 mg daily)

• Class: H1 antihistamines.

• Purpose: Reduce itch, improve sleep, and help prevent scratching.

• Mechanism: Block histamine on itch nerves.

• Side effects: Drowsiness (older agents), dry mouth; modern agents are less sedating.

7. Short prednisone taper (systemic corticosteroid)

• Class: Systemic steroid.

• Dose/Time: Example: 0.5 mg/kg/day for 3–5 days, then taper quickly (doctor-directed).

• Purpose: Rescue for severe, widespread summer flares.

• Mechanism: Strong, rapid immune suppression.

• Side effects: Mood, sleep, blood sugar, BP changes; rebound if tapered too fast—specialist supervision required.

8. Hydroxychloroquine (200 mg once or twice daily)

• Class: Antimalarial, immunomodulator.

• Purpose: Photosensitive lichenoid diseases sometimes respond; may reduce flares across a season.

• Mechanism: Modulates antigen presentation and lysosomal pH; photoprotective properties noted in other photodermatoses.

• Side effects: Eye toxicity is rare at proper dosing → baseline and periodic eye exams.

9. Acitretin (10–25 mg/day)

• Class: Oral retinoid.

• Purpose: For recalcitrant lichenoid disorders (off-label).

• Mechanism: Normalizes keratinocyte differentiation and reduces inflammation.

• Side effects: Dryness, elevated lipids, strict pregnancy avoidance (teratogenic).

10. Isotretinoin (very low dose protocols)

• Class: Oral retinoid.

• Purpose: Select refractory cases with careful specialist oversight.

• Mechanism: Anti-inflammatory/anti-proliferative.

• Side effects: Dryness, mood changes, triglycerides; teratogenic—special program needed.

11. Dapsone (50–100 mg/day)

• Class: Sulfone anti-inflammatory.

• Purpose: Some lichenoid/interface disorders respond.

• Mechanism: Neutrophil and eosinophil modulation.

• Side effects: Hemolysis (check G6PD), methemoglobinemia, rash—lab monitoring required.

12. Methotrexate (7.5–15 mg once weekly)

• Class: Antimetabolite immunomodulator.

• Purpose: Severe, chronic disease unresponsive to topicals.

• Mechanism: Reduces T-cell–driven inflammation.

• Side effects: Liver/BM toxicity—labs and folic acid supplementation.

13. Azathioprine (1–2 mg/kg/day)

• Class: Purine analog immunosuppressant.

• Purpose: Alternative steroid-sparing agent in resistant disease.

• Mechanism: Limits lymphocyte proliferation.

• Side effects: Myelosuppression (check TPMT/NUDT15), infection risk.

14. Mycophenolate mofetil (1–2 g/day in divided doses)

• Class: Immunosuppressant.

• Purpose: Another steroid-sparing option for recalcitrant cases.

• Mechanism: Inhibits purine synthesis in lymphocytes.

• Side effects: GI upset, infection risk; lab monitoring.

15. Topical or short course oral antibiotics in select cases

• Class: Antimicrobials (e.g., metronidazole, tetracyclines).

• Purpose: Anecdotal benefit has been reported in some lichen planus variants; may help secondary infection from scratching.

• Mechanism: Anti-inflammatory effects (e.g., tetracyclines) in skin.

• Side effects: Photosensitivity (notably doxycycline!), GI upset—discuss carefully with your clinician. (Some sources note anecdotal antibiotic use in LP variants; phototherapy is avoided in actinic LP.) DermNet®

Note: Phototherapy is typically avoided in actinic variants because UV is the trigger, unlike other eczema/LP types where phototherapy can help. DermNet®

---

Dietary molecular supplements

Discuss all supplements with your clinician, especially if you are pregnant, on blood thinners, or have medical conditions.

1. Nicotinamide (vitamin B3 amide) 500 mg twice daily

• Function/mechanism: Enhances DNA repair and reduces UV-related immunosuppression; shown to reduce some UV-related skin lesion counts in other settings.

• Role here: Supportive photoprotection during sunny months.

• Note: Do not confuse with niacin (flushing).

2. Polypodium leucotomos extract (PLE) 240–480 mg before sun

• Function/mechanism: Plant antioxidant with photoprotective and anti-inflammatory actions; may reduce UV-induced damage.

• Role: Extra internal support on high-UV days.

3. Vitamin D (per labs; often 800–2000 IU/day)

• Mechanism: Immune modulation and barrier support; deficiency is common in sun-avoidant routines.

• Role: Maintain normal levels while practicing strict photoprotection.

4. Omega-3 fatty acids (EPA/DHA 1–2 g/day)

• Mechanism: Pro-resolving lipid mediators can dampen skin inflammation.

• Role: General anti-inflammatory support.

5. Vitamin C (500–1000 mg/day) + Vitamin E (100–200 IU/day)

• Mechanism: Synergistic antioxidant protection against UV-generated free radicals.

• Role: Adjunct to sunscreen.

6. Carotenoids (beta-carotene/lycopene as labeled)

• Mechanism: May boost minimal erythema dose over weeks.

• Role: Slow, modest internal photoprotection.

7. Zinc (as per RDA unless deficient)

• Mechanism: Co-factor for DNA repair and immune balance.

• Role: Correct deficiency; avoid high chronic doses.

8. Probiotics (strain-specific, daily)

• Mechanism: Gut–skin axis modulation; small studies suggest itch/inflammation reduction in some dermatoses.

• Role: Supportive only.

9. Quercetin (250–500 mg/day)

• Mechanism: Flavonoid with mast-cell stabilizing and antioxidant actions.

• Role: May help itch threshold for some.

10. Green tea extract (EGCG standardized, per label)

• Mechanism: Polyphenols with anti-inflammatory and photoprotective properties.

• Role: Adjunct; avoid with liver disease; use food-grade sources.

---

Regenerative / stem-cell drugs

There are no approved stem-cell or “regenerative” drugs for SALE. For severe, refractory lichenoid disease, dermatologists sometimes use advanced immunomodulators off-label. Below are research-oriented or specialist-only options—not first-line and not home treatments:

1. JAK inhibitors (e.g., upadacitinib, tofacitinib)

• Dose: Specialist-directed.

• Function/mechanism: Block JAK/STAT inflammatory signaling.

• Mechanism in skin: May reduce T-cell–mediated interface dermatitis.

• Caution: Infection, labs, drug interactions.

2. Dupilumab (IL-4Rα blocker)

• Use: Off-label reports in some lichenoid conditions with strong itch.

• Function: Modulates Th2 signals; may reduce pruritus.

• Caution: Conjunctivitis, injection site reactions.

3. Apremilast (PDE-4 inhibitor)

• Function: Lowers pro-inflammatory cytokines via cAMP.

• Caution: GI upset, headache; variable benefit.

4. Low-dose naltrexone (LDN)

• Function: Immune modulation and microglial calming; anecdotal in chronic pruritus.

• Caution: Evidence limited; monitor sleep/mood.

5. Intralesional corticosteroid micro-injections

• Function: Local immune suppression for stubborn plaques.

• Caution: Atrophy risk—experienced hands only.

6. IVIG / cyclosporine “rescue”

• Function: Strong immune modulation in exceptional refractory cases.

• Caution: Significant monitoring; specialist centers only.

---

Surgeries

1. Excision of lesions – Not recommended because SALE lesions are widespread and sun-provoked; cutting them out does not prevent new ones. Surgery is reserved for biopsy to confirm diagnosis.

2. Laser ablation – Not routine; may worsen pigment on sun-exposed skin and does not stop UV-triggered recurrences.

3. Dermabrasion – Not appropriate; risk of scarring/post-inflammatory hyperpigmentation.

4. Skin grafting – No role; lesions are inflammatory, not defects.

5. Photodynamic therapy – Generally avoided in actinic variants; light activation may aggravate.
   Bottom line: Surgery is diagnostic only (biopsy) in unclear cases; medical + UV avoidance is the standard. JAAD

---

Prevention tips

1. Sunscreen SPF 50+ every morning on exposed skin; reapply 2-hourly outdoors.

2. UPF clothing + wide-brim hat + UV sunglasses.

3. Plan outdoor time outside peak UV (before 10 a.m., after 3–4 p.m.).

4. Use shade and window UV films at home and in cars.

5. Avoid known photosensitizing medicines/supplements when possible (discuss with your doctor).

6. Avoid friction on elbows/forearms and abrasive sports surfaces without protective sleeves. PMC

7. Gentle, fragrance-free skincare; moisturize twice daily.

8. Cool skin after heat or sun (cool rinse/compress).

9. Keep an “itch plan” (antihistamine at night if advised, cooling gel packs).

10. Start prevention early (2–3 weeks before summer) and continue through the season.

---

When to see a doctor

• New sun-triggered rash with itchy papules on exposed sites, especially every summer.

• Rapid spread, intense itch, sleep disruption, or pain.

• No improvement after 1–2 weeks of good sun care and over-the-counter measures.

• Face/eye involvement, lip lesions, or children with significant symptoms.

• Medication review if you use drugs linked to photosensitivity.

• Diagnosis confirmation (sometimes a skin biopsy is needed). JAAD

---

What to eat and what to avoid

1. Eat: colorful fruits/vegetables (antioxidants) and lean proteins to support skin repair.

2. Hydrate well; dehydration can worsen skin discomfort in heat.

3. Include omega-3s (fatty fish, flax/chia) several times weekly.

4. Consider green tea as a beverage for polyphenols (if tolerated).

5. Keep vitamin D normal with food/supplement per doctor since you’ll be sun-avoiding.

6. Limit alcohol (can dilate vessels and increase flushing/itch).

7. Avoid fad “photosensitizing” herbal products like St John’s wort unless cleared by your clinician.

8. Be cautious with limes/celery/parsnip outdoors (psoralen-rich foods on skin can cause phototoxic reactions if juice contacts skin in sun).

9. Choose low-irritant foods if you notice personal triggers (spicy foods may increase flushing in some).

10. Balanced, regular meals to maintain energy for consistent self-care.

---

Frequently asked questions (FAQs)

1. Is SALE the same as lichen planus?
   They are related. SALE is a sun-triggered lichenoid eruption on exposed skin. It overlaps with actinic lichen nitidus and lichen planus actinicus—conditions that look similar under the microscope and flare with UV. The Hospitalist BlogPMC

2. How is it diagnosed?
   By history (summer flares), exam (sun-exposed distribution), and sometimes dermoscopy/biopsy. In classic reports, phototesting confirmed sunlight as a trigger. PubMedPMC

3. Will it come back next summer?
   It often recurs in sunny seasons, which is why prevention is key. Karger

4. Does sunscreen really help?
   Yes. For actinic variants, UV is the main driver, so photoprotection is central to control. DermNet®

5. Can phototherapy treat it?
   Unlike some other rashes, phototherapy is usually avoided in actinic lichen planus/actinic variants because UV can worsen the eruption. DermNet®

6. Are there cures?
   There is no permanent cure, but most people do well with sun avoidance + topical anti-inflammatories and short courses of systemic therapy when needed. Karger

7. Is it contagious?
   No. It is an inflammatory reaction pattern, not an infection.

8. Can children get SALE?
   Yes, sun-provoked lichenoid eruptions are reported in children; careful sun protection is essential. JAAD

9. What’s seen under the microscope?
   A lichenoid/interface dermatitis; actinic lichen nitidus shows a classic “claw clutching a ball” pattern in some cases. IJDVL

10. Which body areas are most affected?
    Face, neck, forearms, and the backs of the hands—the places sunlight hits most. PubMed

11. Why do some people get it and others don’t?
    Likely a mix of genetic/immune susceptibility and UV dose; it’s more often reported in darker skin phototypes and subtropical regions. The Hospitalist Blog

12. Will it leave marks?
    It can leave post-inflammatory hyperpigmentation, especially in darker skin. Strict photoprotection helps marks fade faster.

13. Are antibiotics or antifungals used?
    Occasionally in related lichenoid disorders, but evidence is anecdotal; they are not first-line for SALE. DermNet®

14. Can stress cause flares?
    Stress does not cause SALE, but it can worsen itch and scratching. Mind-body tools help reduce this loop.

15. What’s the single most important step?
    Broad-spectrum SPF + UPF clothing + shade, every day of the season. Medications work better when UV exposure is controlled.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 05, 2025.